Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

被引：0
|
作者：
Beatriz Larru
Carmen de Mendoza
José Ma Bellón
Ma Isabel de José
Ma José Mellado
Vincent Soriano
Ma Angeles Muñoz-Fernandez
José T Ramos
机构：
[1] Hospital General Universitario "Gregorio Marañón",Laboratorio de Inmuno
[2] Hospital "Carlos III",Biología Molecular
[3] Hospital Universitario "La Paz",Enfermedades Infecciosas
[4] Hospital "Carlos III",Pediatría
[5] Hospital Universitario "12 de Octubre",Infecciosas
来源：
BMC Infectious Diseases | / 7卷
关键词：
Viral Load; Ritonavir; Virological Response; Amprenavir; Salvage Regimen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Immunological and Virological Responses to Highly Active Antiretroviral Therapy in HIV-1 Infected Children
    Ravinder Singh
    Aparna Mukherjee
    Mohit Singla
    Bimal Kumar Das
    Sushil Kumar Kabra
    Rakesh Lodha
    The Indian Journal of Pediatrics, 2017, 84 : 893 - 896
  • [42] Immunological and Virological Responses to Highly Active Antiretroviral Therapy in HIV-1 Infected Children
    Singh, Ravinder
    Mukherjee, Aparna
    Singla, Mohit
    Das, Bimal Kumar
    Kabra, Sushil Kumar
    Lodha, Rakesh
    INDIAN JOURNAL OF PEDIATRICS, 2017, 84 (12): : 893 - 896
  • [43] HIV/AIDS patients’ perspectives on adhering to regimens containing protease inhibitors
    Valerie E. Stone
    Jennifer Clarke
    Joan Lovell
    Kathleen A. Steger
    Lisa R. Hirschhorn
    Stephen Boswell
    Alicia D. Monroe
    Michael D. Stein
    Tamra J. Tyree
    Kenneth H. Mayer
    Journal of General Internal Medicine, 1998, 13 : 586 - 593
  • [44] Factors associated with virological response and resistance profile in virologically suppressed HIV-1 infected patients switching to a dual therapy containing integrase inhibitors in clinical practice
    Armenia, D.
    Gori, C.
    Forbici, F.
    Borghi, V.
    Gennari, W.
    Bertoli, A.
    Giannetti, A.
    Cicalini, S.
    Mondi, A.
    Colafigli, M.
    Lichtner, M.
    Andreoni, M.
    Mussini, C.
    Antinori, A.
    Silberstein, F. Ceccherini
    Perno, C.
    Santoro, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [45] HIV-1 PROTEASE INHIBITORS CONTAINING STATINE - INHIBITORY POTENCY AND ANTIVIRAL ACTIVITY
    FEHRENTZ, JA
    CHOMIER, B
    BIGNON, E
    VENAUD, S
    CHERMANN, JC
    NISATO, D
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 188 (02) : 865 - 872
  • [46] DISCOVERY OF A NOVEL SERIES OF UREA-CONTAINING HIV-1 PROTEASE INHIBITORS
    TALLEY, JJ
    BRYANT, ML
    CLARE, M
    DECRESCENZO, GA
    GETMAN, DP
    HEINTZ, RM
    HOUSEMAN, KA
    MARR, JJ
    MUELLER, RA
    REED, KL
    VAZQUEZ, ML
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 186 - MEDI
  • [47] Inhibitors of HIV-1 protease: A major success of structure-assisted drug design
    Wlodawer, A
    Vondrasek, J
    ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 1998, 27 : 249 - 284
  • [48] Failure of HIV-1 protease inhibitors to fully suppress viral replication - Implications for salvage therapy
    Deeks, SG
    ANTIVIRAL CHEMOTHERAPY 5: NEW DIRECTIONS FOR CLINICAL APPLICATION AND RESEARCH, 1999, 458 : 175 - 182
  • [49] Protease inhibitors and mortality among children and adolescents infected with HIV-1.
    Barbaro, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13): : 1026 - 1027
  • [50] In vivo virological response in HIV-1 group-O-infected patients to different antiretroviral line regimens
    Charpentier, C.
    Unal, G.
    Depatureaux, A.
    Leoz, M.
    Damond, F.
    Alessandri, E.
    Plantier, J-C
    ANTIVIRAL THERAPY, 2010, 15 : A137 - A137
12345